No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv Yield TTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
WatchlistPaper Trade
![[undefined]](https://static.moomoo.com/nnq/emoji/static/image/default/default-black.png?imageMogr2/thumbnail/36x36 "undefined"){kind=small}
Or are they still playing catch-up to Instagram and TikTok?
103475232 : more than 10x stock, HIMS will buy for further
103475232 : All in , retirement fund
74502850 : Well written and some good facts. We continue to prescribe Nexlizet 1st before PCSK9 injections and that will help the company catch up to Repatha sales. The beauty is Nexlizet is a once a day pill and provides an extra layer of protection by lowering hscrp, sadly PCSK9 injections don't. (972)-649-6511. Heartplace Texas.
DazzlerAus : also trading at close to cash at hand value can't go too much lower you would think
Growth Investor27 : $110 MILLION to $130 MILLION being paid to ESPR this year in milestones from Otsuka, with royalties starting next year at 15% and Canada, Australia & Israel and New Zealend. Then all the royalties diverting back to Esperion from Daiichi Sankyo by 2028 Q3 estimate, bring in $200 million a year by then. Patents extended to 2040. And Triple combo single pill with a statin bring down LDL by 65% is HUGE. The Only STATIN alternative that lowers HSCRP to give additional layer of protection from a HEART ATTACK & STROKE. This stock is crazy undervalued. LOAD & Hold. I take the NEXLIZET myself and have great results with NO side effects.
View more comments...